xl092
Showing 1 - 4 of 4
Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)
Recruiting
- Non-Clear Cell Renal Cell Carcinoma
- XL092
- +2 more
-
Duarte, CaliforniaExelixis Clinical Site #1
Jan 13, 2023
Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)
Recruiting
- Colorectal Cancer
- XL092
- +2 more
-
Omaha, NebraskaExelixis Clinical Site #1
Jul 26, 2022
Renal Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer, Urothelial Carcinoma Trial in United States (XL092,
Recruiting
- Renal Cell Carcinoma
- +3 more
- XL092
- +3 more
-
Tucson, Arizona
- +3 more
Mar 30, 2022
Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,
Recruiting
- Neoplasm Malignant
- +5 more
- XL092
- +2 more
-
Duarte, California
- +55 more
Aug 17, 2022